Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
12.15
+0.11 (0.87%)
At close: Sep 26, 2024, 4:00 PM
12.06
-0.08 (-0.70%)
After-hours: Sep 26, 2024, 6:32 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Novavax stock have an average target of 15.8, with a low estimate of 9.00 and a high estimate of 23. The average target predicts an increase of 30.09% from the current stock price of 12.15.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for Novavax stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $25 → $23 | Strong Buy | Reiterates | $25 → $23 | +89.38% | Aug 12, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -25.90% | Aug 12, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $29 → $25 | Strong Buy | Maintains | $29 → $25 | +105.85% | Aug 2, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $8 | Hold → Sell | Downgrades | $8 | -34.13% | Jul 30, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $12 → $18 | Hold | Maintains | $12 → $18 | +48.21% | Jun 14, 2024 |
Financial Forecast
Revenue This Year
754.43M
from 983.71M
Decreased by -23.31%
Revenue Next Year
500.08M
from 754.43M
Decreased by -33.71%
EPS This Year
-1.01
from -5.41
EPS Next Year
-0.28
from -1.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 803.3M | 795.9M | 599.6M | ||
| Avg | 754.4M | 500.1M | 434.7M | ||
| Low | 701.1M | 226.4M | 277.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -18.3% | 5.5% | 19.9% | ||
| Avg | -23.3% | -33.7% | -13.1% | ||
| Low | -28.7% | -70.0% | -44.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.56 | 1.76 | 1.07 | ||
| Avg | -1.01 | -0.28 | 0.08 | ||
| Low | -1.26 | -1.63 | -0.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.